Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Stock Option Activity (Detail)

v3.22.2.2
Stockholders' Equity - Stock Option Activity (Detail)
 9 Months Ended 12 Months Ended
Aug. 31, 2022
USD ($)
$ / shares
shares
Nov. 30, 2021
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted 52,500  
Service-Based Vesting Condition Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding at November 30, 2021 537,443  
Granted 52,500  
Exercised (182,229)  
Expired/forfeited (87,250)  
Outstanding at August 31, 2022 320,464 537,443
Exercisable at August 31, 2022 231,230  
Outstanding at November 30, 2021, Weighted Average Exercise Price | $ / shares $ 5.76  
Granted, Weighted Average Exercise Price | $ / shares 13.20  
Exercised, Weighted Average Exercise Price | $ / shares 3.03  
Expired/forfeited, Weighted Average Exercise Price | $ / shares 6.15  
Outstanding at August 31, 2022, Weighted Average Exercise Price | $ / shares 8.42 $ 5.76
Exercisable at August 31, 2022, Weighted Average Exercise Price | $ / shares $ 7.27  
Outstanding, Weighted Average Remaining Contractual Term (Years) 4 years 8 months 23 days 5 years 2 months 19 days
Exercisable at August 31, 2022, Weighted Average Remaining Contractual Term (Years) 5 years 14 days  
Outstanding at November 30, 2021, Aggregate Intrinsic Value | $ $ 3,564,067  
Exercised, Aggregate Intrinsic Value | $ 645,304  
Expired/forfeited, Aggregate Intrinsic Value | $ 150,075  
Outstanding at August 31, 2022, Aggregate Intrinsic Value | $ 136,007 $ 3,564,067
Exercisable at August 31, 2022, Aggregate Intrinsic Value | $ $ 136,007